Drug profile · INN
nonacog alfa
BENEFIX
nonacog alfa (BENEFIX) is a coagulation factor ix exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02BD04
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — nonacog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
nonacog alfa (BENEFIX) is a coagulation factor ix exogenous protein.
Key facts
INN nonacog alfa
Brand BENEFIX
Mechanism Coagulation factor IX exogenous protein
Target Coagulation factor IX
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD04
Mechanism of action
Coagulation factor IX exogenous protein
Primary target: Coagulation factor IX
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nonacog alfa?
nonacog alfa (BENEFIX) is a coagulation factor ix exogenous protein.
What is the brand name for nonacog alfa?
BENEFIX is a marketed brand name for nonacog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.